Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71205-246

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71205-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-246-90 (Atorvastatin 10 mg 30 Bottle Label)

This is a description of a medication package containing two sets of tablets with Atorvastatin Calcium 10mg composition, each set containing 30 tablets. The package is manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India. The tablets are oval-shaped and white to off-white, biconvex, film-coated and are stored at 20-25 degrees Celsius. The package has a lot number of 00000 and an expiration date of 00/00/00.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

This appears to be a graph/chart displaying the cumulative hazard percentage over time (in years) for a placebo group and a group that took Atorvastatin. There is a statistically significant difference in hazard between the two groups, with Atorvastatin having lower hazard. However, without additional context or information, the meaning and significance of the primary endpoint and hazard in this study cannot be determined.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

This is a statistical report presenting the percentage of subjects experiencing an event in a study related to the use of Atorvastatin at 10 mg and 80 mg doses. The results show that the risk of developing major cardiovascular conditions was significantly reduced in the group taking Atorvastatin 80 mg compared to the group taking Atorvastatin 10 mg. The graph also indicates that the time to the first major cardiovascular endpoint was 5 years.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.